Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Practice‑Changing Therapies for HFpEF/HFmrEF: SGLT2i, MRAs and Incretin Trials
Author(s): Harriette Van Spall , Maja Cikes Added: 1 week ago
Dr Harriette Van Spall (McMaster University, CA) hosts this Masterclass on the contemporary management of heart failure with preserved and mildly reduced ejection fraction, joined by Professor Maja Čikeš (University Hospital Centre Zagreb, HR) for a focused review of the datasets that are redefining treatment in HFpEF/HFmrEF. Framed around the transition from a field once dominated by therapeutic… View more

Heart Failure
‘Residual Congestion’ in HF
Author(s): Aleksandra Gasecka , Aleksander Siniarski Added: 1 year ago

Imaging & Diagnostics

Heart Failure
Justin Beilby
Research Area(s) / Expertise:

Expertise

Heart Failure
Job title: Deputy Vice Chancellor Research
Personal History Prof Justin Beilby is a researcher who currently works as the Deputy Vice Chancellor Research for Torrens University Australia. He is based in Adelaide, Australia. Academic History Prof Justin Beilby completed his Bachelor of Medicine, Bachelor of Surgery, Master of Public Health and Doctor of Medicine qualifications at the University of Adelaide, Australia. … View more
The Evolving Treatment Landscape for HFpEF in Cardiac Amyloidosis
Author(s): Added: 7 months ago
AHA Scientific Sessions 2025 - Dr Sarah Cuddy (Brigham and Women's Hospital, US) joins us to discuss the role of non-disease modifying treatments including SGLT2 inhibitors, mineralocorticoid receptor antagonists, GLP-1 receptor agonists, and implantable hemodynamic monitors in cardiac amyloidosis, and what this means for managing heart failure in this unique patient population.Interview… View more

Heart Failure
Worsening Heart Failure Case Study – Inpatient Setting
Author(s): Gianluigi Savarese Added: 1 year ago
Prof Gianluigi Savarese presents a case study of a HFrEF patient with a history of disease progression and worsening of symptoms despite GDMT. The patient is admitted for IV diuresis and Professor Savarese asks, ‘what are the next steps in managing this patient?' Watch the second case by Gianluigi Savarese on Worsening Heart Failure – Outpatient Setting and a case from Javed Butler who present on… View more

Heart Failure
Management Essentials
Management Essentials

Podcast Episode

Added: 2 years ago
In this episode, Prof Juan Pablo Kaski is joined by Dr Carolyn Ho for a 20-minute discussion on essential management topics, including phenotyping, triaging, symptomatic care, and transplant considerations. Join them for valuable insights and expert perspectives. View more

Heart Failure
Personal History Dr Rafiudeen is based in Melbourne, Australia where he works in the department of cardiology of The Northern Hospital. Academic History Dr Rafiudeen obtained his MBBS (Hons) from the University of Melbourne. He completed his cardiology training at the Royal Hobart Hospital, Royal Melbourne Hospital and Western/Sunshine Hospitals in Melbourne. He is currently… View more
Kidney Function Trajectories Before and After HF Hospitalisation
Author(s): Nicolas Girerd Added: 1 year ago
ESC HF 25 - Real-world findings suggest kidney function decline could precede heart failure events by up to a year.Prof Nicolas Girerd (University Hospital of Nancy, Nancy, FR) discusses real-world findings from pooled trials EPHESUS, EMPHASIS-HF and BARCELONA. The study investigated if longitudinal changes in kidney function could help identify patients with HFrEF at a higher risk of… View more

Cardiovascular Kidney Metabolic

Heart Failure
HFSA 25: Sex-Specific Outcomes of Tirzepatide in Obesity-Related HFpEF
Author(s): Barry Borlaug Added: 8 months ago
HFSA 25 - Sex-specific outcomes of tirzepatide in obesity-related HFpEF showed that at baseline, women with HFpEF had more severe heart failure symptoms.Dr Barry Borlaug (Mayo Clinic, US) joins us to discuss a prespecified secondary analysis from the SUMMIT trial, examining sex-specific effects of tirzepatide in patients with heart failure with preserved ejection fraction and obesity.The SUMMIT… View more

Cardiovascular Kidney Metabolic

Heart Failure
Multimodality Imaging in Hypertrophic Cardiomyopathy
Author(s): Daniel Escribano , Elena Díaz-Peláez , Victoria Delgado Added: 1 month ago

Imaging & Diagnostics

Electrophysiology & Arrhythmia